⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

HSIC

Henry Schein, Inc.

Healthcare · Medical Distribution

87.97USD

-0.8900 (-1.00%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$1.35▼$1.3759
Next quarter$1.44▲$1.42103
Current year$5.38▲$5.34141
Next year$6▲$5.91132

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$1.24$1.27+0.03 (+2.5%)
2026-03-31$1.22$1.32+0.10 (+8.4%)
2025-12-31$1.29$1.34+0.05 (+3.5%)
2025-09-30$1.28$1.38+0.10 (+7.9%)

Wall Street coverage

167 ratings from 32 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
BTIGMaintainedBuy$100 $110Aug 19, 2026
BarclaysMaintainedOverweight$86 $100Aug 6, 2026
UBSMaintainedNeutral$89 $94Aug 5, 2026
CitigroupMaintainedBuy$100 $112Aug 5, 2026
BTIGReiteratedBuy$100Aug 5, 2026
Piper SandlerMaintainedOverweight$91 $95Jul 29, 2026
UBSMaintainedNeutral$85 $89Jul 28, 2026
BMO CapitalInitiatedMarket Perform$85Jul 9, 2026
BTIGUpgraded from NeutralBuy$100Jun 11, 2026
UBSMaintainedNeutral$87 $85May 6, 2026
MizuhoMaintainedNeutral$88 $82May 6, 2026
Morgan StanleyMaintainedUnderweight$61 $64Apr 24, 2026
BTIGInitiatedNeutral—Apr 16, 2026
CitigroupInitiatedBuy$100Apr 15, 2026
Evercore ISI GroupMaintainedOutperform$100 $90Apr 8, 2026
Barrington ResearchMaintainedOutperform$79 $97Feb 25, 2026
UBSMaintainedNeutral$79 $87Feb 25, 2026
JP MorganMaintainedOverweight$78 $92Feb 25, 2026
MizuhoMaintainedNeutral$81 $88Feb 25, 2026
Morgan StanleyMaintainedUnderweight$58 $61Feb 25, 2026
Wells FargoMaintainedEqual-Weight$76 $87Feb 25, 2026
Evercore ISI GroupMaintainedOutperform$90 $100Feb 25, 2026
Leerink PartnersMaintainedMarket Perform$75 $87Feb 24, 2026
BairdUpgraded from NeutralOutperform$78 $100Feb 23, 2026
MizuhoMaintainedNeutral$74 $81Jan 20, 2026

Insider transactions

79 filings from 26 insiders · 21 buy / 2 sell over 6m

Officers and directors of HSIC, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Albertini AndreaOfficer, CEO, Global Dist. & Tech.Other4.0k——Sep 8, 2026
Albertini AndreaOfficer, CEO, Global Dist. & Tech.Tax603$88.86$54kSep 8, 2026
DANIEL WILLIAM KDirectorGrant2.2k——Jun 12, 2026
BERGMAN STANLEY MDirectorGift50——May 26, 2026
BERGMAN STANLEY MDirectorGift50——May 21, 2026
BERGMAN STANLEY MDirectorGift1.0k——May 19, 2026
DANIEL WILLIAM KDirectorBuyindirect10.0k$69.19$692kMay 11, 2026
POPECK THOMAS COfficerSell1.4k$72.79$99kMar 19, 2026
ETTINGER MICHAEL S.Chief Operating OfficerGift2.3k——Mar 17, 2026
BERGMAN STANLEY MDirectorGift400——Mar 16, 2026
BERGMAN STANLEY MDirectorGift970——Mar 12, 2026
KUEHN KURT PDirectorSell2.8k$78.96$225kMar 10, 2026
MLOTEK MARK EOfficerGift1.5k——Mar 6, 2026
SEROTA SCOTT PHILIPDirectorGrant2.6k——Mar 6, 2026
ETTINGER MICHAEL S.Chief Operating OfficerGrant27.1k——Mar 6, 2026
HERRING JOSEPH LDirectorGrant2.6k——Mar 6, 2026
MLOTEK MARK EOfficerGrant27.1k——Mar 6, 2026
TUCKSON REED VAUGHNDirectorGrant2.6k——Mar 6, 2026
HOMBACH ROBERT J. CPADirectorGrant2.6k——Mar 6, 2026
DERBY DEBORAH M.DirectorGrant2.6k——Mar 6, 2026

Analyst Notes

Sign in to write

No analyst notes on HSIC yet.

Analyst Ratings

16 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current45710Buy2.29
1 mo ago45710Buy2.29
2 mo ago45710Buy2.29
3 mo ago45610Buy2.25
Price target$98.19$64.00 – $112.00
+11.6% to target